Fisher Scientific to Divest Atos Medical AB
Acquired by Fisher in its 2003 transaction with Perbio Science AB, Sweden-based Atos Medical is the world leader in providing devices designed to rehabilitate the voice and pulmonary functions after laryngectomy for the treatment of cancer. Atos also provides other devices for the treatment of ear and sinus diseases.
The transaction is subject to customary closing conditions. Fisher expects to complete the transaction by the beginning of the second quarter.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.